Immediate post-operative MRI suggestive of the site and timing of glioblastoma recurrence after gross total resection: A retrospective longitudinal preliminary study

European Radiology

Volumn 23, Issue 6, 2013, Pages 1467-1477

  Smets, Thibault ^a   Lawson, Tévi Morel ^a   Grandin, Cécile ^a   Jankovski, Aleksandar ^b,c   Raftopoulos, Christian ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Glioblastoma recurrence; Intra operative MRI; MRI; Neurosurgery; rCBV

Indexed keywords

GADOTERATE MEGLUMINE; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; LONGITUDINAL STUDY; MALE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CONTRAST MEDIA; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878725160     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2762-1     Document Type: Article

References (37)

1. States Central Brain Tumor Registry of the United (2010) CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2004-2006. Central Brain Tumor Registry of the United States (CBTRUS), Chicago. Available via http://www.cbtrus.org/2010-NPCR-SEER/ CBTRUS-WEBREPORT-Final-3-2-10.pdf. Accessed 05 May 2010
2. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45-60, discussion 60-41
3. Allahdini F, Amirjamshidi A, Reza-Zarei M, Abdollahi M (2010) Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival? World Neurosurg 73:128-134, discussion e116
4. Sanai N, Polley MY, Mcdermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3-8
5. Lacroix M, Abi-Said D, Fourney DR, et al. (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198
6. Hentschel SJ, Sawaya R (2003) Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Control 10:109-114
7. Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13:1339-1348
8. Jeremic B, Grulicic D, Samardzic M, et al. (1997) The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme. Srp Arh Celok Lek 125:93-98
9. Ushio Y, Kochi M, Hamada J, Kai Y, Nakamura H (2005) Effect of surgical removal on survival and quality of life in patients with supratentorial glioblastoma. Neurol Med Chir (Tokyo) 45:454-460, discussion 460-451
10. Vidiri A, Carapella CM, Pace A, et al. (2006) Early post-operative MRI: correlation with progression-free survival and overall survival time in malignant gliomas. J Exp Clin Cancer Res 25:177-182
11. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011-1018
12. Li SW, Qiu XG, Chen BS, et al. (2009) Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Chin Med J (Engl) 122:1245-1249
13. Mcgirt MJ, Chaichana KL, Gathinji M, et al. (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110:156-162
14. Murakami R, Hirai T, Nakamura H, et al. (2010) Recurrence patterns of glioblastoma treated with postoperative radiation therapy: relationship between extent of resection and progression-free interval. Int J Radiat Oncol Biol Phys 78(3 Suppl 1):S289-S290
15. Ewelt C, Goeppert M, Rapp M, Steiger HJ, Stummer W, Sabel M (2011) Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol 103:611-618
16. Massey V, Wallner KE (1990) Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys 18:395-398
17. Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M (1994) Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 30:146-149
18. Wick W, Stupp R, Beule AC, et al. (2008) A novel tool to analyze MRI recurrence patterns in glioblastoma. Neuro Oncol 10:1019-1024
19. Schaefer PW, Grant PE, Gonzalez RG (2000) Diffusion-weighted MR imaging of the brain. Radiology 217:331-345
20. Di Costanzo A, Scarabino T, Trojsi F, et al. (2006) Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology 48:622-631
21. Khan RB, Gutin PH, Rai SN, Zhang L, Krol G, Deangelis LM (2006) Use of diffusion weighted magnetic resonance imaging in predicting early postoperative outcome of new neurological deficits after brain tumor resection. Neurosurgery 59:60-66, discussion 60-66
22. Pirzkall A, Mcgue C, Saraswathy S, et al. (2009) Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro Oncol 11:842-852
23. Khayal IS, Polley MY, Jalbert L, et al. (2010) Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme. Neuro Oncol 12:908-916
24. Blasel S, Franz K, Ackermann H, Weidauer S, Zanella F, Hattingen E (2011) Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery. J Neurooncol 103:575-584
25. Li Y, Lupo JM, Polley MY, et al. (2011) Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. Neuro Oncol 13:546-557
26. Stecco A, Pisani C, Quarta R, et al. (2011) DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma. J Neurooncol 102:261-271
27. Leysalle A, Haberer S (2010) Mise au point sur la pseudoprogression après chimioradiothérapie dans les glioblastomes. Oncologie 12:559-564
28. Jankovski A, Francotte F, Vaz G, et al. (2008) Intraoperative magnetic resonance imaging at 3-T using a dual independent operating room-magnetic resonance imaging suite: development, feasibility, safety, and preliminary experience. Neurosurgery 63:412-424, discussion 424-416
29. Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use. Oxford University Press, Oxford
30. Knauth M, Aras N, Wirtz CR, Dorfler A, Engelhorn T, Sartor K (1999) Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am J Neuroradiol 20:1547-1553
31. Ekinci G, Akpinar IN, Baltacioglu F, et al. (2003) Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence. Eur J Radiol 45:99-107
32. Keles GE, Anderson B, Berger MS (1999) The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52:371-379
33. Aronen HJ, Gazit IE, Louis DN, et al. (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51
34. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F (2006) Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48:150-159
35. Sehgal V, Delproposto Z, Haddar D, et al. (2006) Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24:41-51
36. Lupo JM, Cha S, Chang SM, Nelson SJ (2007) Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. AJNR Am J Neuroradiol 28:1455-1461
37. Lehmann P, Saliou G, De Marco G, et al. (2011) Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 81:522-527